The most common blood-based biomarker studies in pancreatic cancer include the analysis of circulating mutations in cfDNA, and the mutated genes most frequently detected are KRAS, TP53, APC, SMAD4 or FBXW7 [34]. Here, SMAD4 is linked to familial pancreatic carcinoma.